Faster method to fight Bluetongue virus developed

Bs_logoImage
Press Trust of India London
Last Updated : Oct 08 2014 | 7:55 PM IST
British researchers have developed a faster method of producing an effective vaccine for the devastating animal disease caused by the Bluetongue virus.
Insects are the carrier of the Bluetongue virus that infects cattle, sheep and some other wild ruminants.
Infected animals experience a range of symptoms, which are fatal in some cases. There are also indirect impacts including weight loss and reduced milk production.
The new and cost effective method allows the production of a reliable type of inactivated vaccine using a "synthetic biology" approach, a study done by scientists from the University of Glasgow, in collaboration with Merial Animal Health reported.
This method doesn't rely on the use of live, infectious virus and could mean that it is safer than other types of vaccines.
The "synthetic" viral particles are created rapidly in the laboratory using sequence information from the genetic material of the virus, the study reported.
Synthetic vaccines can cure the animal 6 months faster than the traditional medicine, it said.
This breakthrough means that a reliable product could become available more quickly following the detection of an outbreak caused by a newly emerging BTV strain.
Professor Massimo Palmarini, Director of the MRC University of Glasgow Centre for Virus Research and lead researcher said: overall, this vaccine platform can significantly reduce the time taken from the identification of newly emerging BTV strains to the development and production of new effective vaccines."
"They can be brought to the market more quickly but with the same level of quality and reliability as traditional vaccines. This is a big step towards a more sustainable, effective and rapid method of disease prevention," Palmarini said.
Previous prevention measures include culling of animals and use of inactivated vaccines which contain viruses that have been killed by chemical methods.
However, despite being effective, they only offer protection against a specific strain of the virus.
Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 08 2014 | 7:55 PM IST